Page 3 - David Essam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Where all our short—term memory is stored. - alzheimer's gradually destroys key areas of the brain involved in memory and understanding. david is one of nearly 2,000 patients who took part in a major trial of a new drug — lecanemab. as normal, if you just - lift your arm up there for me. it involved having an infusion every two weeks. lecanemab didn't stop alzheimer's... i'lljust get you started here. ..but over 18 months, it's slowed its progression by about a quarter. this is so exciting because now we're getting results, - the first results that - are indicating that the drug is success...

For the first time, seems to slow alzheimer's, the most common form of demenita. the drug — lecanemab — only works in the early stages of the disease and it does have serious side effects — but scientists believe it could herald a new era of treatment. our medical editor, fergus walsh, reports. could you get the broccoli out of the fridge for me, please? yeah. 0k. david essam is 78 and has early stage alzheimer's. it's taken away his independence. he's now totally reliant on me or other people around him. he used to be a joiner, but no longer remembers how to use his woodworking tools. i...

Lecanemab works by clearing amyloid from the brain. david and his wife cheryl can't be sure if the drug is making a difference, but they're delighted to have taken part in the trial. when we first began this two and a half years ago, we didn't necessarily think it would help us, but we felt we were doing something and could help future generations. it's just a horrible, nasty thing. if somebody can slow it down and then eventually get it stopped altogether, you know, it'd be brilliant. at least half a million people across the uk are living with alzheimer's, by far the most common form of deme...

Because of the disease. alzheimer's gradually destroys key areas of the brain involved in memory and understanding. david is one of nearly 2,000 patients who took part in a major trial of a new drug, lecanemab. as normal, if you just lift your arm up there for me. it involved having an infusion every two weeks. lecanemab didn't stop alzheimer's... i'lljust get you started here. ..but over 18 months, it slowed its progression by about a quarter. this is so exciting because now we're getting results, the first results that are indicating that the drug is successfully treating the underlying caus...

With one expert saying "we now know what we need to do to develop effective drugs". and there are still several stages before lecanamab can be made widely available in the uk. 0ur medical editor fergus walsh has more. could you get the broccoli out of the fridge for me, please, love? yeah. 0k. david essam is 78 and has early stage alzheimer's. it's taken away his independence. he's now totally reliant on me or other people around him. he used to be a joiner, but no longer remembers how to use his woodworking tools. i would have liked to have still been making my furniture, which i can't do. so...